(Date:1/8/2009)...long-standing assessment for heart risk may not be...n. 8 (HealthDay News) -- Two studies, from the Uni...acy and value of the long-established Framingham R...scular death. , The Framingham score, based on ...etts community, allows doctors to assess risk on t...
(Date:1/8/2009)...U.S.-Based Alliance of relief organizations offers...INGTON, Jan. 8 Despite ...ivery of food and medical supplies to residents of...ple still lack access to food, clean water and med...id organizations working in the region see this ar...
(Date:1/8/2009)...Senator Dole introduces Senator Daschle at his con...th and Human Services , , , WASHINGTON, Jan. ...ter (BPC) founding board member Senator Tom Daschl...ices Secretary, was introduced by fellow BPC found... hearing today. The hearing was convened by the Se...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
Breaking Medicine News(10 mins):Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:FDA Backs Cholesterol Drug Vytorin 2(Date:1/8/2009)..., CHICAGO, Jan. 8 If you are ...t today, you,re not alone. Half of the people taki...bed. The reasons are,varied -- they forget, are b...cision not to. Noncompliance has been called the A...eon General Everett Koop commented, "Drugs don,t,...
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/ ...that predict a high likelihood of relapse in child...ugh the researchers caution that further research ...lled IKZF1 or IKAROS, lead to leukemia relapse... future diagnostic tests to assess the risk of tre...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua H...hua.com ), the worldwide leader in using stem cell...ounced today six new globally experienced addition...ntly expand the hospital,s treatment capabilities ...ents. The six senior doctors include the distingui...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In recent...er, University of Memphis , scientists found that...rn(R), is the first and only proven ingredient to ...thereby increasing blood nitrate/nitrate (NOx) in ...dilator and enables an increase in blood flow to t...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Genmab A S Changes Board Management Auditors 5741 1Genmab A S Changes Board Management Auditors 5741 2Genmab A S Changes Board Management Auditors 5741 3IDC ranked no 6 of Canadas 100 fastest growing companies by PROFIT Magazine 20874 1IDC ranked no 6 of Canadas 100 fastest growing companies by PROFIT Magazine 20874 2IDC ranked no 6 of Canadas 100 fastest growing companies by PROFIT Magazine 20874 3Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 20872 1Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 20872 2Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 20872 3Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 20872 4Medline Signs 3 Year Purchasing Agreement for Mouth Rinse From Chester Labs 5740 1Medline Signs 3 Year Purchasing Agreement for Mouth Rinse From Chester Labs 5740 2...ase III trial data underlines M6G,s,benefit compar...pain , CAMBRIDGE, England, 7th March 2007 - CeNeS ...d biopharmaceutical company today,announces additi...),of M6G (morphine-6-glucuronide) in over 500 pati...a released on 20th February,showed that M6G provid...
...0,000 Locations Across the Genome From 242,Patient...Acute,Lymphoblastic Leukemia, Suggesting New Targe... 2007 /PRNewswire/ -- Investigators at,St. Jude Ch...sly,unsuspected mutations that contribute to the f... (ALL), the most common cancer in,children. The di...
Other Medicine Technology:CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3The Summit SI Spinal Fixation System offers a comprehensive solution for rigid posterior fixation of the occipito-cervicothoracic regions of the spine. The simplicity and versatility of this system a
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Decker Rongeurs
Adson Cranial Rongeur
Medicine Products: